These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Spontaneous coronary artery dissection in association with cabergoline therapy. Saleh Z; Koshy S; Sidhu V; Opgenorth A; Senaratne J BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33563672 [TBL] [Abstract][Full Text] [Related]
3. The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma. Gürbüz F; Yağcı-Küpeli B; Kör Y; Yüksel B; Zorludemir S; Gürbüz BB; Küpeli S J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):159-63. PubMed ID: 23945126 [TBL] [Abstract][Full Text] [Related]
4. A Case Report of Delusions in a Patient Receiving Cabergoline Therapy for Prolactinoma: Pathophysiology and Proposed Treatment With Aripiprazole. Springer C; Rodgers R; Vivino G; Attanagoda S; Miks CD Clin Neuropharmacol; 2023 May-Jun 01; 46(3):126-127. PubMed ID: 37191567 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous coronary artery dissection associated with oral contraceptive use: a case report and review of the literature. Evangelou D; Letsas KP; Korantzopoulos P; Antonellis I; Sioras E; Kardaras F Int J Cardiol; 2006 Oct; 112(3):380-2. PubMed ID: 16256224 [TBL] [Abstract][Full Text] [Related]
6. Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma. Menon LP; Rahman W J Investig Med High Impact Case Rep; 2021; 9():23247096211029750. PubMed ID: 34218714 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous healing of spontaneous coronary artery dissection: a case report. Erdim R; Gormez S; Aytekin V J Invasive Cardiol; 2008 Aug; 20(8):E237-8. PubMed ID: 18688070 [TBL] [Abstract][Full Text] [Related]
8. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Delgrange E; Maiter D; Donckier J Eur J Endocrinol; 1996 Apr; 134(4):454-6. PubMed ID: 8640297 [TBL] [Abstract][Full Text] [Related]
9. Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia. Miki N Intern Med; 2001 Sep; 40(9):845-6. PubMed ID: 11579939 [No Abstract] [Full Text] [Related]
10. Cabergoline can induce mania with psychotic features in bipolar I disorder: a case report. Rovera C; Cremaschi L; Thanju A; Fiorentini A; Mauri MC; Serati M; Lindenmayer JP; Altamura AC Asian J Psychiatr; 2016 Aug; 22():94-5. PubMed ID: 27520906 [TBL] [Abstract][Full Text] [Related]
11. Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis. Hu J; Zheng X; Zhang W; Yang H Pituitary; 2015 Oct; 18(5):745-51. PubMed ID: 25500765 [TBL] [Abstract][Full Text] [Related]
12. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Dhanwal DK; Sharma AK Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817 [TBL] [Abstract][Full Text] [Related]
13. Recurrent spontaneous coronary artery dissection: First case report in men with three episodes of spontaneous coronary dissection in separate vascular territories. Papireddy MR; Nandish S; Mishkel GJ Catheter Cardiovasc Interv; 2016 Apr; 87(5):E192-6. PubMed ID: 26252543 [TBL] [Abstract][Full Text] [Related]
15. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Balarini Lima GA; Machado Ede O; Dos Santos Silva CM; Filho PN; Gadelha MR Pituitary; 2008; 11(3):287-92. PubMed ID: 17570067 [TBL] [Abstract][Full Text] [Related]
16. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene? Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630 [TBL] [Abstract][Full Text] [Related]